“This is very good news and I hope that in the future the knowledge gained from this vaccine will actually allow researchers to develop even more effective vaccines.”
It is in these terms that Dr. John Nkengasong, director of the African Center for Disease Control and Prevention (CDC of Africa) reacted to the support given by the World Health Organization for a massive deployment of the RTS, S or Mosquirix.
The WHO said its decision was based largely on the results of clinical trials in Ghana, Kenya and Malawi, where the vaccine has been administered to 800,000 children since 2019.
We discussed the development of vaccines against malaria with Dr. Hermann Sorgho, a researcher in parasitology at Nanoro’s clinical research unit in Burkina Faso. He specializes in parasitic vaccine research and participated in phase III research on RTS, S. Dr. Hermann Sorgho is currently working on R21, another vaccine in development against malaria.
Click on the image above to hear their explanations.
WeaPlay, WordPress Theme, Business Consulting Nulled, Avada 7.4 Nulled, Newspaper – News & WooCommerce WordPress Theme, Nulledfire, Elementor Pro Weadown, Astra Pro Nulled, Plugins, Rank Math Seo Pro Weadown, Woodmart Theme Nulled, Elementor Pro Weadown,Woodmart Theme Nulled, Wordfence Premium Nulled, Flatsome Nulled, Yoast Nulled, Woocommerce Custom Product Ad, Jannah Nulled, Dokan Pro Nulled, Fs Poster Plugin Nulled, Jnews 8.1.0 Nulled, PW WooCommerce Gift Cards Pro Nulled, Newspaper 11.2, Premium Addons for Elementor, Slider Revolution Nulled, Wpml Nulled, PHP Script, WP Reset Pro, Consulting 6.1.4 Nulled